Skip to main content
. 2011 Jan 23;5(2):208–216. doi: 10.1007/s11764-011-0172-z

Table 1.

Patient characteristics of 91 responders

Median age 62 (37–92)
Median follow-up (months) 100 (66–131)
FIGO Stage/substage, (N%)
 Ib2 13 (14%)
 IIb 65 (72%)
 IIIa/IIIb 12 (13%)
 IVa 1 (1%)
Histology
 Squamous carcinoma 80 (88%)
 Adenocarcinoma 8 (9%)
 Adenosquamous carcinoma 3 (3%)
Treatment modalities
 Type 1 (EBRT Dose 50/45 Gy + ICRT) 75 (82%)
 Type 2 (EBRT Dose 45/60 Gy + ICRT) 9 (10%)
 Extended radiation field 7 (8%)